Palifosfamide

Related by string. palifosfamide * * palifosfamide administered intravenously . Palifosfamide Zymafos TM . Palifosfamide delivers . Intravenous palifosfamide . oral palifosfamide . palifosfamide Zymafos TM . intravenous palifosfamide *

Related by context. All words. (Click for frequent words.) 72 Meets Primary Endpoint 72 Tezampanel 71 Phase IIb Trial 71 CYT# potent vascular disrupting 71 mertansine 70 pan HDAC inhibitor 70 Phase 2b Clinical Trial 70 Hsp# Inhibitor 70 sodium glucose cotransporter 70 erlotinib Tarceva ® 70 Gemzar ® 70 oral prodrug 70 Xanafide 70 Initiates Phase II 70 Pafuramidine 69 PEGylated anti 69 ADP receptor antagonist 69 dependent kinase inhibitor 69 ocular formulation 69 Aflibercept 69 Disease IBD 69 PEGylated Fab fragment 69 Antitumor Activity 69 Solazed ™ 69 Aliskiren 69 JAK Inhibitor 69 AEG# 69 MEK Inhibitor 69 developing Bicifadine serotonin 69 histone deacetylase HDAC inhibitor 68 Drug Candidate 68 R roscovitine CDK cyclin 68 Pivotal Phase III 68 Novel Oral 68 TNF Tumor Necrosis Factor 68 orally administered inhibitor 68 HDAC Inhibitor 68 investigational oral inhibitor 68 huC# DM4 68 Wafer polifeprosan 68 Advanced Renal Cell 68 MKC# MKC# PP 68 sapropterin dihydrochloride 68 MAGE A3 ASCI 68 refractory chronic lymphocytic 68 Irinotecan 68 Complicated Skin 68 Orally administered 68 drug pipeline TAFA# 68 Epratuzumab 68 Prolongs Survival 68 Sapacitabine 68 Investigational Compound 68 sunitinib Sutent ® 68 FOLOTYN ® 68 INVANZ 68 Romidepsin 67 Seliciclib CYC# 67 targeted radiotherapeutic 67 Initiate Clinical Trial 67 Copegus ® 67 Peginterferon 67 cetuximab Erbitux R 67 Metastatic Melanoma 67 dasatinib Sprycel ® 67 Zorbtive TM 67 Paraplatin ® 67 Fludara ® 67 novel VDA molecule 67 Inhalation Aerosol 67 Voreloxin 67 Initiates Enrollment 67 Granted Orphan Drug 67 Methylnaltrexone 67 Monoclonal Antibody 67 bevacizumab Avastin R 67 Phase IIb Clinical Trial 67 CYP#A# CYP#D# 67 mGluR5 negative 67 Receives Orphan Drug 67 Interferon Beta 67 Dapagliflozin 67 Presents Preclinical Data 67 dihydrochloride Tablets 67 ODT metoclopramide HCl PEPCID 67 Cutaneous T 67 #D#C# 67 TRANSDUR ™ 67 interferon gamma 1b 67 Tamibarotene 67 Systemic Delivery 67 docetaxel Taxotere ® 67 cell lymphoma CTCL 67 Mylan Receives Approval 67 PRTX 67 Alemtuzumab 67 amprenavir 67 Pegylated 67 Serostim ® 67 R Saizen R 67 SAR# [004] 67 INCB# [003] 67 N acetylgalactosamine 6 67 brand ciclesonide HFA 67 Maribavir 67 active moiety 67 dihydrochloride 67 Preclinical Data 67 cardiometabolic diseases Glucophage 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 Bevacizumab 67 ALN HPN 67 abacavir sulfate lamivudine 67 CysDisplay R 67 Clinical Trial Results 66 Bafetinib 66 Combination REOLYSIN R 66 polymerase inhibitor 66 Ranolazine 66 Completes Patient Enrollment 66 alpha interferons 66 PRN FDA Approves 66 Carfilzomib 66 Completes Enrollment 66 Ofatumumab 66 Diovan Exforge Tekturna Zelnorm 66 Phase 2b Trial 66 Serostim R 66 Oral Fingolimod 66 samarium Sm 66 HuCAL PLATINUM ® CysDisplay 66 Copegus R 66 Albuferon TM 66 trastuzumab Herceptin R 66 NOTE POSIDUR ™ 66 Phase III Clinical Trial 66 Refractory Hodgkin Lymphoma 66 TRANSDUR ® 66 Bortezomib 66 Zolinza 66 Calcitonin 66 Perifosine 66 Elvitegravir 66 INTEGRILIN R 66 diarrhea predominant irritable 66 small molecule defensin 66 bevacizumab Avastin ® 66 PNP inhibitor 66 JAK1 66 Presents Preclinical 66 Chronic Hepatitis C 66 Soriatane R 66 XL# anticancer compounds 66 Golimumab 66 NDA Submission 66 BUPHENYL 66 vinca alkaloids 66 Study Evaluating 66 Glufosfamide 66 rHuPH# recombinant human 66 ceftazidime 66 virus HCV protease inhibitor 66 Submits NDA 66 oral proteasome inhibitor 66 Well Tolerated 66 Randomized Double blind 66 PDX pralatrexate 66 Pazopanib 66 Initiates Clinical 66 peptidic compound 66 candesartan cilexetil 66 Mg Usa 66 VISICOL R 66 Leukine ® 66 Demonstrates Potent 66 Kuvan R 66 methylnaltrexone bromide 66 pralatrexate injection folate analogue 66 Tyrosine Kinase Inhibitor 66 familial amyloidotic polyneuropathy FAP 66 non nucleoside inhibitor 66 evaluating tivozanib 66 Phase III Trial 66 topically applied SEPA 65 highly selective inhibitor 65 Files IND 65 MyVax R 65 OMNARIS HFA 65 Granulocyte Colony Stimulating Factor 65 Anti Tumor Activity 65 proteasome inhibitor 65 MGd 65 NXL# 65 Factor Receptor 65 Navelbine ® 65 Receives Orphan Drug Designation 65 5 FU leucovorin 65 HGS ETR1 mapatumumab 65 Mg Uk 65 HuCAL GOLD R 65 selective kinase inhibitor 65 modified glutathione analog 65 thalidomide Thalomid 65 Phase 2a Clinical Trial 65 TO AVOID PREGNANCY WHILE 65 myelofibrosis polycythemia vera 65 Initiates Phase III 65 Phase #b/#a clinical 65 Protease Inhibitor 65 Xcytrin R 65 Panzem R 65 lexidronam injection 65 hyperphenylalaninemia HPA due 65 Diabetic Neuropathy 65 Squamous 65 Pegloticase 65 Intravenous Human 65 Metastatic Colorectal Cancer 65 hypereosinophilic syndrome 65 AAG geldanamycin analog 65 Humanized Anti 65 Investigational Treatment 65 FDA APPROVES 65 Vidaza ® 65 Recombinant Human 65 Pemetrexed 65 targeting CD# 65 phase IIb clinical 65 R lenalidomide 65 alkylating agent 65 Daptomycin 65 BCG refractory carcinoma 65 cutaneous T 65 Pegasys ® 65 sorafenib Nexavar 65 Potassium Chloride Sodium Ascorbate 65 Trastuzumab DM1 65 2 methoxyestradiol 65 metastatic neuroendocrine tumors 65 phase IIb trial 65 Presents Positive 65 Azedra 65 DOXIL R 65 BAG# BAG# BAG# BAG# 65 vapreotide acetate 65 Initiate Phase 65 Pharmacokinetics PK 65 Haemophilus b Conjugate 65 mGluR5 NAM 65 Telaprevir VX 65 corticotropin injection 65 allosteric modulator NAM 65 Neulasta R 65 NS#/#A protease 65 SUPPRELIN R LA 65 Pooled Analysis 65 Preclinical Study 65 INCB# [001] 65 Lubiprostone 65 Pralatrexate 65 Dasatinib 65 nucleoside reverse transcriptase inhibitor 65 Achieves Primary Endpoint 65 imatinib Gleevec ® 65 Demonstrates Significant 65 Solazed TM 65 pegylated interferons 65 IL# PE#QQR 65 HuMax EGFr 65 Advanced Melanoma 65 Lenalidomide 65 receptor tyrosine kinase inhibitor 65 Nilotinib 65 Soft Tissue Sarcoma 65 novel topoisomerase 65 Oral Mucositis 65 Traficet EN 65 Phase 2b Study 65 sorafenib tablets 65 Anticancer Compound 65 Initiates Phase 65 cutaneous T cell 65 Patient Enrollment 65 5 Fluorouracil 65 acetonide FA 65 novel histone deacetylase 65 multi kinase inhibitor 65 topical gel formulation 65 SABER ™ 65 First Patient Dosed 65 oral nucleoside analogue 65 treat benign prostatic 65 IL #E 65 GW# [003] 65 recurrent metastatic ovarian cancer 65 chronic eosinophilic leukemia 65 delivers fluocinolone acetonide FA 64 Placebo Controlled Trial 64 Controlled Trial 64 investigational humanized monoclonal antibody 64 HGS ETR2 64 QUADRAMET R 64 interferon alfa 2b 64 gemcitabine Gemzar 64 Initiates Clinical Trial 64 Successfully Completes Phase 64 Vidaza R 64 Saizen ® 64 TKB# 64 IgG1 antibody 64 aripiprazole Abilify 64 Seliciclib 64 HCV protease inhibitor 64 induced macular edema 64 CCX# 64 ZOLINZA 64 Safinamide 64 PROSTASCINT R 64 Belimumab 64 Sphingomab 64 sapropterin dihydrochloride Tablets 64 Bavituximab 64 Trial Evaluating 64 Oral Suspension Oral Suspension 64 Sym# 64 Cethromycin 64 pegylated 64 Pharmacokinetic Study 64 AVONEX ® 64 indinavir Crixivan 64 JAK2 Inhibitor 64 Monotherapy 64 Kinase Inhibitor 64 Phase III Pivotal 64 Anti Tumor 64 somatropin Kuvan R 64 Nucleoside 64 Iluvien ® 64 AVASTIN 64 Veronate R 64 Capecitabine 64 Alfacell proprietary ribonuclease 64 Sevelamer 64 XOPENEX HFA 64 Nitazoxanide 64 Tesetaxel 64 BiovaxID TM 64 Vitro Activity 64 forodesine 64 Gel repository corticotropin injection 64 UPLYSO 64 TELINTRA 64 include PLX IBD 64 Patients Treated With 64 Adenoscan R 64 pan histone deacetylase 64 topoisomerase II inhibitor 64 Fluticasone 64 intravesical infusion therapy 64 Talabostat 64 PDE4 inhibitor 64 JAK inhibitor 64 5 HT3 antagonist 64 Epothilones 64 Phase 2a Trial 64 Replacement Therapy 64 metabolic disorders Saizen R 64 CD# CEA 64 Cetrorelix 64 Panzem R NCD 64 selective antagonist 64 Adalimumab 64 Silodosin 64 PEG SN# 64 Bicalutamide 64 Personalized Immunotherapy 64 YONDELIS 64 XL# XL# 64 FUSILEV ® 64 FASLODEX 64 Pivotal Phase 64 Aurexis R 64 Exelixis compounds 64 ELADUR TM 64 panitumumab Vectibix 64 Vaccine Adjuvant 64 DDP# 64 Retinoic Acid 64 Peginterferon alfa 2b 64 Enzyme Replacement Therapy 64 Rebif ® 64 Antiviral Activity 64 fosbretabulin 64 IgG1 monoclonal antibody 64 Vidofludimus 64 IMA# 64 estrogen receptor antagonist 64 Diabetic Macular Edema 64 Prednisporin 64 chimeric monoclonal antibody 64 orally bioavailable 64 mesylate 64 COPEGUS R 64 Etoposide 64 fluoroquinolone antibiotic 64 RNAi Therapeutic 64 ara C 64 Parkinson disease levodopa induced 64 Numoisyn Liquid 64 Interferon alpha 64 Previously Treated 64 Leukemias 64 Laboratory pH Electrodes 64 administered concomitantly 64 Moxifloxacin 64 Peginterferon Alfa 2a 64 Receives Fast Track 64 antifungal agent 64 MEK inhibitors 64 XmAb# 64 octreotide acetate 64 salmeterol inhalation powder 64 Therapeutic Competitors Companies 64 Crohn disease CD 64 Azixa 64 product platforms AZX# 64 TAFA# 64 interferon beta 1a infertility 64 Randomized Phase 64 small molecule Hedgehog 64 Angioedema 64 ABLYNX 64 immunomodulatory properties 64 DexaSite 64 R metformin Concor 64 Kepivance 64 Liprotamase 64 Allovectin 7 R 64 transthyretin mediated amyloidosis ATTR 64 Vascular Disrupting Agent 64 CCR9 antagonist 64 metastatic castration resistant 64 Eltrombopag 64 CTAP# Capsules 64 Elagolix 64 favorable pharmacokinetic profile 64 LEP ETU 64 small molecule tyrosine 63 SPRYCEL ® 63 nucleoside analog 63 2 inhibitor CYT# 63 Demonstrates Positive 63 LY# [002] 63 Elotuzumab 63 tumor xenograft models 63 HuLuc# 63 candidates Azedra 63 Interferon beta 1a 63 dextromethorphan quinidine 63 metformin HCl 63 substantially excreted 63 orally bioavailable mimics 63 trabectedin 63 voriconazole 63 5 HT6 receptor 63 HuCAL PLATINUM R 63 modulator SERM 63 immunosuppressive compound 63 METOZOLV TM ODT metoclopramide 63 Chemokine Receptor 63 CCR5 antagonist 63 MKC# MT 63 vitreoretinal disorders 63 AzaSite Plus 63 Onalta ™ 63 alpha folate receptor 63 Antigenics QS 63 small molecule thrombopoietin 63 Transdermal Patch 63 Gefitinib 63 erlotinib Tarceva R 63 Pivotal Trial 63 generation Hsp# inhibitor 63 ritonavir boosted 63 peripherally acting 63 Brentuximab Vedotin SGN 63 HCV RNA polymerase 63 ALN TTR 63 Iloperidone 63 somatostatin analogue 63 Soriatane 63 HMG CoA reductase inhibitors 63 ziprasidone Geodon 63 Vinorelbine 63 ALVESCO ® 63 Tibotec Therapeutics division 63 mGluR2 positive 63 Ovitrelle R Serostim 63 lintuzumab SGN 63 vinca alkaloid 63 Single Dose 63 Entereg R 63 Camptosar ® 63 AZT zidovudine Retrovir 63 Commences Phase 63 oral dual endothelin 63 IMiDs ® 63 arthritis PsA 63 Omacetaxine 63 LENALIDOMIDE 63 ribavirin Copegus 63 HCV protease 63 Daclizumab 63 erythematosus 63 Universal Flu Vaccine 63 includes S. anginosus 63 Long Term Efficacy 63 OncoVEX GM CSF 63 Zemiva ™ 63 Campath ® 63 targeting Inflammatory Bowel 63 rusalatide acetate 63 histone deacetylase inhibitor 63 POLYSHIELD ® POLYCLEAR ® 63 stable nucleic acid 63 EGFr humanized monoclonal antibody 63 lenalidomide Revlimid R 63 Archexin 63 Aurora Kinase 63 ALVESCO R 63 vaginal candidiasis 63 DAVANAT 63 Ambrisentan 63 TLK# 63 Erlotinib 63 active comparator 63 ACTEMRA TM 63 Refractory Peripheral T 63 CIMZIA ™ 63 Microspheres 63 humanized anti 63 Homspera TM 63 AVOREN 63 Xyfid TM 63 oral ferric iron 63 Solzira TM 63 ALN PCS 63 pathophysiological effects 63 Romiplostim 63 selective inhibition 63 Regenerative Cells 63 Kuvan sapropterin dihydrochloride 63 alefacept 63 GSK '# 63 ENMD # 63 CD# monoclonal antibody 63 AEGR 63 systemic immunosuppressive drugs 63 vaccine GRNVAC1 63 Xeloda ® 63 nevirapine Viramune 63 uricase 63 metaglidasen 63 PEGINTRON TM 63 novel emulsion formulation 63 oxaliplatin Eloxatin 63 R bisoprolol Euthyrox 63 Cannabinor 63 abacavir Ziagen 63 Factor VIIa 63 anticancer compound 63 LEUKINE 63 Bucindolol 63 Cleviprex TM clevidipine 63 docetaxel Taxotere R 63 IS FOR INFORMATIONAL 63 class anticancer quinolone 63 ALVESCO 63 Metabolic Efficiency 63 Kamada AAT 63 CORT # 63 Milatuzumab 63 prostanoid 63 Trastuzumab 63 Epivir ® 63 cleavable linker 63 ThermoDox R 63 adenosine injection 63 Zoraxel 63 LE SN# 63 phase III isavuconazole 63 selective androgen receptor modulator 63 Piperacillin 63 NR2B selective 63 antibody MAb 63 Present Preclinical Data 63 sodium benzoate prescription 63 esomeprazole Nexium 63 vinorelbine tartrate 63 ® famotidine 63 Orally Active 63 Cell Lung Cancer 63 OMNARIS Nasal Spray 63 Epidermal Growth Factor Receptor 63 protein tyrosine phosphatase 1B 63 carbamazepine phenobarbital phenytoin rifampin 63 Naive Patients 63 Interferon Gamma 63 Severe Sepsis 63 etanercept Enbrel 63 SAR# [002] 63 Completes Dosing 63 iobenguane 63 #mg/#mg 63 Antigen Specific 63 polysaccharide polymer 63 Vandetanib 63 trastuzumab DM1 T DM1 63 Amrubicin 63 nucleoside analogues 63 Atopic Dermatitis 63 pentadentate logo R 63 systemic juvenile idiopathic 63 amifostine 63 investigational pan BCR 63 IMiDs ® compound 63 DURECT proprietary 63 ELADUR ™ 63 metastatic malignant 63 Myelodysplastic Syndrome MDS 63 kidney urologic 63 eltrombopag 63 Therapeutic Vaccine 63 CD4 monoclonal antibody 63 liposomal formulation 63 Double Blind Placebo 63 Oral Formulation 63 Advancing Drugs 63 FDA Accepts 63 posaconazole 63 FOLFOX6 chemotherapy regimen 63 targets Galectin receptors 63 CoFactor 63 HCV NS5B polymerase 63 GATTEX TM 63 Orphan Drug designations 63 Aeolus Pharmaceuticals Announces 63 Mouse Model 63 Improve Survival 63 miconazole Lauriad R 62 Squalamine 62 Study Demonstrates 62 Malignant Melanoma 62 PKC# 62 EGFr 62 Aurora kinase 62 Loceryl ® 62 RapMAT R 62 itraconazole Sporanox 62 HFA MDI 62 Temsirolimus 62 Alocrest 62 Mitoxantrone 62 treat male hypogonadism 62 Adjuvant Treatment 62 Relapsed Refractory 62 developing Zerenex ferric 62 HuCAL GOLD ® 62 drug ISA# 62 Kit CD# positive 62 Amplimexon 62 HCl PEPCID ® famotidine 62 Oracea TM 62 BYETTA ® 62 Nexavar ® 62 Zysolin TM 62 AMMONUL R sodium phenylacetate 62 Systemic lupus erythematosus SLE 62 MTP inhibitor 62 nilotinib Tasigna ® 62 leukemia CLL 62 CCR2 62 markets COLAZAL 62 FOLFOX6 62 MT# MEDI 62 non nucleoside HCV 62 interferon alfacon 1 62 REVLIMID lenalidomide 62 Lupus Nephritis 62 PGL# 62 HuMax CD4 62 Reports Preclinical Data 62 mitogen activated ERK kinase 62 Oxybutynin 62 GTC recombinant human 62 Civacir 62 Expanded Indication 62 Novel Antibiotic 62 formerly LymphoStat B 62 topical antifungal 62 oral picoplatin 62 MEK inhibitor 62 Eluting Stent 62 Azacitidine 62 LymphoStat B belimumab 62 Antitumor 62 STELARA TM 62 gefitinib Iressa 62 personalized cellular immunotherapy 62 Tiotropium 62 Chronic HCV 62 homozygous familial hypercholesterolemia 62 Randomized Double Blind 62 Decitabine 62 Viprovex TM 62 mapatumumab 62 beta 1a 62 anti EGFR antibody 62 Solution XOPENEX HFA 62 IgG1 62 PRT# 62 leading oral taxane 62 standard chemotherapy regimen 62 delafloxacin 62 Kuvan TM sapropterin 62 TRIOLEX HE# APOPTONE HE# 62 complement inhibitor eculizumab 62 RAPTIVA 62 AVE# 62 oral JAK1 62 monoclonal antibody conjugated 62 Files Investigational 62 Adenoviral 62 Preclinical studies suggest 62 PROCTOCORT R 62 NS5b 62 Initiates Clinical Trials 62 adalimumab Humira 62 Dose Escalation 62 MGCD# [001] 62 Prestara TM 62 Immunotherapeutic 62 antibody fragment 62 Pivotal Study 62 humanized monoclonal 62 ANYARA 62 Intravenous CP 62 DU #b 62 selective modulator 62 EDEMA3 62 white petrolatum Ointment 62 * olmesartan medoxomil 62 Thalomid ® 62 markets HP Acthar 62 bevacizumab Avastin 62 Emollient Foam 62 recurrent glioblastoma multiforme 62 By JENNIFER LEARN 62 metastatic GIST 62 Friedreich Ataxia FRDA 62 radiation sensitizer 62 Luteinizing Hormone Releasing Hormone 62 Vicinium TM 62 J Am Coll 62 HGS ETR1 62 PEGylated 62 XP# XP# 62 Clolar ® 62 bosutinib 62 phenylalanine ammonia lyase 62 Is Well Tolerated 62 LY# [003] 62 Gonal f R 62 acyclovir Lauriad R 62 anti angiogenic agent 62 JAK inhibitors 62 Deforolimus 62 HSP# inhibitor 62 Apaziquone 62 R brand levalbuterol 62 Vitrasert R 62 proprietary polysaccharide 62 Oral Solution OSMOPREP 62 Fluconazole 62 Adjuvant Chemotherapy 62 arsenic trioxide injection 62 LEVAQUIN 62 Orthop Surg 62 trastuzumab Herceptin ® 62 essential thrombocythemia 62 Topical Suspension 62 COX Inhibiting Nitric Oxide 62 selective A2A adenosine receptor 62 Platelet Derived Growth 62 severe hypercholesterolemia 62 VYVANSE TM lisdexamfetamine 62 demonstrated antitumor activity 62 essential thrombocythemia ET 62 Lanthanum Carbonate 62 pancreatic prostate 62 Fingolimod 62 Medoxomil 62 PRESS RELEASE ARE FORWARD 62 systemic RNAi therapeutic 62 może być niezwłocznie przeredagowana 62 Anidulafungin 62 3TC lamivudine Epivir 62 miconazole 62 sulodexide 62 Intermezzo ® zolpidem tartrate 62 compound PMX # 62 product candidate Lpathomab 62 tenofovir Viread 62 azelastine 62 Aplidin R 62 RapMAT ® 62 Randomized Phase II 62 Antiangiogenic 62 VivaGel TM 62 cMET 62 KL4 Surfactant 62 Through Glycoscience 62 GVAX ® 62 VEGF inhibitors 62 candidates Azedra TM 62 TRX1 62 S1P antibody 62 Myelofibrosis 62 potentially hepatotoxic 62 Octreolin 62 meropenem 62 oncolytic virus therapies 62 Tolerability 62 Pathway Inhibitor 62 Durezol TM 62 WAS PREPARED BY KINBAURI 62 Agenerase 62 vascular disrupting agents 62 Tanespimycin 62 vorinostat 62 gastrointestinal stromal tumors GIST 62 polyneuropathy HIV DSP 62 Cholesterol Lowering Drug 62 ® DYTEK ® FRESHFX 62 Naproxcinod 62 liver colon rectal 62 CYC# 62 topical non steroidal 62 Oracea ® 62 Seasonal Allergic Rhinitis 62 HQK 62 RON Notch 62 novel synthetic PEGylated 62 non peptidic protease 62 Cardium Therapeutics TM 62 Neulasta ® 62 OXi# 62 XOPENEX R 62 Tofacitinib 62 Sudhir Agrawal D.Phil 62 ALN TTR# 62 Luveris R Ovidrel R 62 refractory gout 62 IN PATIENTS WITH 62 Triolex 62 R rilonacept Injection 62 molecular imaging radiopharmaceutical 62 RhuDex ® 62 TG# [003] 62 Selective Inhibitor 62 JDEMALINE@ENQUIRER.COM 62 sulindac 62 bendamustine 62 FOLFIRI 62 combines bupropion 62 epithelial tumors 62 Janus kinase 62 Dupuytren Contracture 62 Vidaza azacitidine 62 Aptamer 62 echinocandin 62 See CLINICAL PHARMACOLOGY 62 INFeD R 62 #HT# 62 induced mucositis 62 highly purified pasteurized 62 hyaluronidase enzyme 61 BUPHENYL R 61 Unresectable 61 Degarelix 61 nucleotide analogue 61 rxRNA 61 PULMICORT 61 treat chronic sinusitis 61 Topline Results 61 rasagiline tablets 61 Obatoclax 61 KNS # 61 sunitinib Sutent 61 therapeutically inactive prodrug 61 PROSPECTUS PROXY STATEMENT BECAUSE 61 efalizumab 61 Bosutinib 61 Bezielle 61 orally dosed 61 BAG# 61 Diovan HCT 61 Coadministration 61 fallopian tube cancers 61 dasatinib Sprycel 61 5 fluorouracil leucovorin 61 Demonstrated Significant 61 D aspartate NMDA receptor 61 Statistically Significant 61 Panzem NCD 61 sunitinib malate 61 Perforomist ™ Inhalation Solution 61 advanced metastatic renal 61 successfully commercialize Iluvien 61 AQ4N 61 J Am Acad 61 ® adefovir dipivoxil 61 R bendamustine hydrochloride 61 Fluorouracil 61 Hypercholesterolemia 61 Anticancer Activity 61 telomerase therapeutic 61 Tumor Necrosis Factor 61 plasma kallikrein inhibitor 61 DIURIL R 61 Argatroban 61 candidate XP# 61 Allovectin 7 ® 61 sertraline Zoloft 61 TYZEKA 61 CDK cyclin dependent 61 Improves Survival 61 potent inhibitor 61 severe hepatomegaly 61 Overactive Bladder 61 SPL# Gel vaginal microbicide 61 octreotide implant 61 actinic solar 61 hypertrichosis occurred 61 Ciclesonide 61 Dalbavancin 61 PEP# [003] 61 II Clinical Trial 61 atrasentan 61 Myelodysplastic Syndromes 61 Investigational Drug 61 Tiuxetan 61 ciclesonide 61 Carcinoid tumors 61 NEUGENE 61 Akt inhibitor 61 Parnate 61 Anavex #-# 61 Genasense ® 61 motexafin gadolinium Injection 61 Ozarelix 61 Topical Solution 61 PD LID 61 Ocrelizumab 61 IAP inhibitor 61 somatostatin analog 61 norepinephrine reuptake inhibitor 61 RELOVAIR ™ 61 thrombolytic agent 61 Phase 1b Clinical Trial 61 rilonacept Injection 61 Vorinostat 61 IAP inhibitors 61 humanized monoclonal antibody 61 PEGylated interferon 61 lesinurad 61 R roscovitine 61 Benign Prostatic Hyperplasia 61 Adjunctive Therapy 61 Evoclin R 61 Sciences ABthrax Albuferon 61 Begins Dosing 61 ® tiagabine hydrochloride 61 SIMCOR 61 Diabetic Nephropathy 61 VivaGel ™ 61 Bazedoxifene 61 MOVIPREP R 61 MT#/MEDI-# 61 Trabectedin 61 Previously Untreated 61 non squamous NSCLC 61 benzoic acid hyoscyamine sulfate 61 Thrombin topical Recombinant 61 Sangamo BioSciences Announces 61 Prodarsan R 61 cisplatin gemcitabine 61 R famotidine 61 SMaRT ™

Back to home page